Thanks, John, and good evening, everyone. I'll provide a more detailed overview of our 2022 financial performance and then turn it back to John before we open up the call for questions. Unless stated otherwise, all of the comparisons and variance commentary is on a year-over-year basis. As John mentioned, for the full year 2022, net sales increased 41% to $378.5 million compared to $268 million, the increase was driven by continued strong sales execution and growth of our metal card business domestically and abroad for both new and existing customers. Gross profit for 2022 increased 52% to $220 million or 58% of net sales compared to $145 million or 54% of net sales. Throughout the year we benefited from higher card issuance volumes as well as operating efficiencies as we scaled business, which was partially offset by higher supply chain costs in the back half of the year versus the first half. Net income for 2022 increased 58% to $132 million compared to $83 million and adjusted EBITDA increased 33% to $136 million compared to $102 million. The increase was driven by continued strong growth on the top line, gross margin expansion and increases from revaluation of the earnout in the warrants. Adjusted EBITDA margin for the year came in at 36% compared to 38% with a decrease driven by a combination of factors, including public company costs, a one-time settlement of a dispute through arbitration, which has been consistently disclosed in our quarterly filings and continued investment in the Arculus platform. As Jon mentioned earlier, the net impact from Arculus revenue and investments was minus $21 million for all of 2022, and in line with our latest guidance issued last year and significantly lower than the $33 million in our original projections. This reflects our continued commitment to driving profit. We’re prudently managing our investments. Turning to our balance sheet. On December 31, 2022, we had cash and cash equivalents of $14 million and total debt of $363 million, which includes approximately $233 million of term loan and $130 million of exchangeable notes. This results in a total net debt of $349 million. We want to provide both our overall debt leverage ratio and our bank agreement secured debt leverage ratio as our bank agreement is calculated with slight differences. At December 31, our overall leverage ratio improved to 2.6x based on net debt of $349 million and trailing 12 month adjusted EBITDA of $136 million. This compares to 3.6x at December 31, 2021 with the improvement driven by a combination of paying down debt and growing EBITDA. At December 31, 2022, we had a bank agreement secured debt leverage ratio of 1.6x based on a net debt of $233 million and trailing 12 month bank adjusted EBITDA of $144 million. This compares to 2.4x at December 31, 2021. Taking a look at our cash flow statement. We generated operating cash flow of $93 million and we believe our cash balances, cash flow generation and debt facilities provide us with more than adequate working capital to fund our operations. Let’s turn quickly to fourth quarter results. Fourth quarter 2022 net sales grew 25% to $94 million compared to $75 million the same quarter last year. Gross margin for the quarter increased to 54% versus 52% for the same quarter the prior year. Net income for the fourth quarter of 2022 was up 12% to $22 million. This includes a $4 million net benefit for fair value adjustments associated with the mark-to-market of warrants and the earnout. Adjusted EBITDA for the quarter was $31 million, up 44% compared to $21 million last year and adjusted EBITDA margin in Q4 improved to 33% compared to 28% in the fourth quarter of 2021. Arculus revenue and investments resulted in a net impact of approximately minus $6 million for the fourth quarter. Let’s take a look at our net sales trends. Taking a closer look at the sales trends, we continue to generate strong growth both in the U.S. and internationally with them up 35% and 68% for the full year of 2022, respectively. U.S. growth was once again driven by the strength of our sales execution and favorable industry trends, while international was up due to the expansion of our international sales team, continued distributor growth and strong customer demand. Turning to earnings per share. As discussed last year, we adopted a method under GAAP for calculating basic and diluted EPS, which allows us to allocate changes in fair value adjustments of mark-to-market instruments among the public company and the operating subsidiaries to better reflect the actual economic impact of conversion of such instruments on our net income and our per share basis. The reason we are doing this is that we believe this method better reflects the economic impact for shareholders. Our Q2, Q3 and Q4 EPS figures as reported are consistently calculated under this GAAP measure. Having said that, let me run through our EPS calculations. GAAP EPS for the 12 months ended December 31, 2022 was $1.21 per basic share and $1.13 per diluted share. GAAP EPS for the fourth quarter was $0.14 for both basic and diluted shares. You could read through the footnotes on the slides that take you through the complexities of the allocation of net income due to the Up-C structure and the shares that are included in the basic and diluted calculations. Note that the fair value adjustments in the quarter and the full year have been allocated among the operating companies that come to pre-allocation net income. Now, let’s take a look at non-GAAP earnings per share. On Slide 18 and in our MD&A, we’re also providing a non-GAAP adjusted net income and adjusted EPS that takes out the impact of the non-cash fair value adjustments such as stock-based comp, warrant and earnout re-valuations. We believe that this provides a clearer picture of the economics of the company’s operating results. Please note, these non-cash adjustments can have both a positive and a negative impact on our net income. With that background, our non-GAAP EPS for the full year 2022 was $1.10 per basic share and $0.94 per diluted share, while non-GAAP EPS for the fourth quarter was $0.23 per basic share and $0.20 per diluted share. In the appendix, you’ll find a reconciliation between GAAP and non-GAAP net income used in these calculations. I’ll now hand it back over to Jon for a final summary before we take questions.